Last reviewed · How we verify

NCT06611280

Deuterium Metabolic Imaging in People with Multiple Sclerosis

Recruiting now Last updated 9 October 2024
What this trial tests

trial testing No Interventions in Multiple Sclerosis (MS) - Relapsing-remitting in 20 participants. Currently enrolling.

Timeline
1 October 2024
Primary endpoint
1 October 2025
1 May 2026

Quick facts

Lead sponsorUniversity of Aarhus
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment20
Start date1 October 2024
Primary completion1 October 2025
Estimated completion1 May 2026
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

Adults 18 to 60, any sex, with Multiple Sclerosis (MS) - Relapsing-remitting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this case-control study is to investigate glucose brain metabolism in people with multiple sclerosis and age- and sex-matched healthy controls. The main questions it aims to answer are: * How does brain glucose metabolism in people with multiple sclerosis compare to age- and sex-matched healthy controls? * How is the brain glucose metabolism of people with multiple sclerosis associated with disease severity? Participants will come in for testing lasting approximately three hours and undergo deuterium metabolic imaging, physical function test, cognitive function test, and answer survey.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exploring brain glucose metabolism in multiple sclerosis: A deuterium metabolic imaging study.
    Khan AS, Trosborg KK, Vaeggemose M, Gaemelke T, et al · · 2026 · PMID 41934329 · DOI 10.1177/0271678x261437569

Verify or expand the search:

Other trials of No Interventions

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis (MS) - Relapsing-remitting

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611280.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing